0001193125-25-291332.txt : 20251121 0001193125-25-291332.hdr.sgml : 20251121 20251121160214 ACCESSION NUMBER: 0001193125-25-291332 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251121 DATE AS OF CHANGE: 20251121 EFFECTIVENESS DATE: 20251121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Galecto, Inc. CENTRAL INDEX KEY: 0001800315 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 371957007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-564756 FILM NUMBER: 251507809 BUSINESS ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 45-70-70-52-10 MAIL ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Galecto Inc. DATE OF NAME CHANGE: 20200116 D 1 primary_doc.xml X0708 D LIVE 0001800315 Galecto, Inc. 75 State Street Suite 100 Boston MA MASSACHUSETTS 02109 (+45) 70 70 52 10 DELAWARE None Galecto Inc. Corporation true Hans T. Schambye c/o Galecto, Inc. 75 State Street, Suite 100 Boston MA MASSACHUSETTS 02109 Executive Officer Director Lori Firmani c/o Galecto, Inc. 75 State Street, Suite 100 Boston MA MASSACHUSETTS 02109 Executive Officer Garrett Winslow c/o Galecto, Inc. 75 State Street, Suite 100 Boston MA MASSACHUSETTS 02109 Executive Officer Carl Goldfischer c/o Galecto, Inc. 75 State Street, Suite 100 Boston MA MASSACHUSETTS 02109 Director Julianne Bruno c/o Galecto, Inc. 75 State Street, Suite 100 Boston MA MASSACHUSETTS 02109 Director Christopher Cain c/o Galecto, Inc. 75 State Street, Suite 100 Boston MA MASSACHUSETTS 02109 Director Jayson Dallas c/o Galecto, Inc. 75 State Street, Suite 100 Boston MA MASSACHUSETTS 02109 Director Peter Harwin c/o Galecto, Inc. 75 State Street, Suite 100 Boston MA MASSACHUSETTS 02109 Director Amit Munshi c/o Galecto, Inc. 75 State Street, Suite 100 Boston MA MASSACHUSETTS 02109 Director Biotechnology Decline to Disclose 06b false 2025-11-12 false true true 0 Jefferies LLC 2347 None None 520 Madison Avenue New York NY NEW YORK 10022 CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE GA GEORGIA IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS Leerink Partners LLC 39011 None None 1301 Avenue of the Americas, 5th Floor New York NY NEW YORK 10019 CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE GA GEORGIA IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS UBS Securities LLC 7654 None None 11 Madison Avenue New York NY NEW YORK 10010 CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE GA GEORGIA IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS LifeSci Capital, LLC 168404 None None 1700 Broadway, 40th Floor New York NY NEW YORK 10019 CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE GA GEORGIA IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS 285000000 285000000 0 false 48 0 17100000 0 false Galecto, Inc. /s/ Hans T. Schambye Hans T. Schambye President & Chief Executive Officer 2025-11-21